Blood Sample Testing
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest special notice from .
- Solicitation number
- 12172529
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q508 Hematology & Oncology
- Place of performance
- Camp Lejeune, North Carolina 28547, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency (DHA) is seeking sources to provide non-personal services for transportation, packaging supplies, and blood testing for the Blood Donor Center located at Naval Medical Center Camp Lejeune. The Government is seeking sources that can meet requirements such as blood sample testing, including tests for infectious diseases regulated by the FDA and CDC, and completing transportation, testing, and results within 24 hours of the pick-up request. Interested sources must submit a capability statement that includes management, technical data, and cost information, not exceeding three pages, by the due date of November 16, 2024. The Government will consider all capability statements received and make a determination on whether to conduct a competitive procurement or proceed with sole source contracts.
This pre-solicitation notice has no set-aside designation. The Government has not provided any information about potential incumbents or current contractors. Additionally, the notice does not include any details on potential award values or budget ranges, or the quantity of goods or timeline for services.
Notice text
The Defense Health Agency (DHA) is seeking sources to provide non-personal services for transportation, packaging supplies, and blood testing for the Blood Donor Center located at Naval Medical Center Camp Lejeune 100 Brewster Blvd Camp Lejeune NC, 28547. The Government is seeking sources that can meet all of the following requirements:
1. Blood Sample Testing to include:
- Blood Donor Panel (basic infectious disease testing)
- Antibody Titers
- HLA 1-2
- Babesia
- West Nile Virus
2. Test blood samples for any infectious diseases that are regulated by the FDA and CDC to ensure to quality and potency of the blood product being released in a timely manner.
3. Transport, Testing, and Results will need to be accomplished within 24 hours from pick-up request.
This sources sought notice is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management, technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed three (3) (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with the sole source contracts.
Capability statements are due by 9:00 AM Eastern Time, November 16, 2024. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following addresses: tanya.c.richardson.civ@health.mil and gerrie.m.johnson.civ@health.mil
Notice history
| Notice | Type | Posted |
|---|---|---|
| Blood Sample Testing | Award Notice | |
| Blood Sample Testing | Special Notice | |
| This notice | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity